| Revenue | SEK 8,7M | +31% |
| EBITDA | SEK 3,6M | +1057% |
| Net profit | SEK -4,3M | -336% |
| Total assets | SEK 165M | -2% |
| Equity | SEK 72M | -6% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 195 | 6 178 | 6 422 | 6 670 | 8 708 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 627 | 3 496 | 683 | −373 | 3 571 |
| Depreciation & amort. | −3 949 | −3 948 | −5 116 | −5 116 | −5 116 |
| EBIT | −1 322 | −452 | −4 433 | −5 489 | −1 545 |
| Net financials | −1 074 | −890 | −1 175 | −3 489 | −4 281 |
| Profit before tax | −2 397 | 4 357 | 37 522 | −979 | −4 286 |
| Tax | −0 | −0 | −0 | −5 | −0 |
| Net profit | −2 397 | 4 357 | 37 522 | −984 | −4 286 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 143 330 | 147 483 | 187 709 | 167 892 | 164 966 |
| Equity | 35 379 | 39 736 | 77 259 | 76 275 | 71 990 |
| Long-term debt | 106 630 | 106 630 | 106 630 | 90 149 | 1 642 |
| Short-term debt | 1 320 | 1 117 | 3 820 | 1 468 | 91 334 |
| Total debt | 107 950 | 107 747 | 110 450 | 91 617 | 92 976 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Per Jonas Kjerfve | Board of Directors | 0 companies |
| Per Johan Linus Bellander | Deputy Board Member | 0 companies |
| Åsa Kristina Lundström | Chairman | 0 companies |
| Jan-Fredrik Henriksson | Deputy Board Member | 0 companies |